Ricardo Dolmetsch
Consultant / Advisor at Trialspark, Inc.
Net worth: 211 108 $ as of 2024-05-30
Profile
Ricardo Dolmetsch is currently an Advisor at Formation Bio Inc. He previously worked as a Senior Director at The Allen Institute for Brain Science and as the Global Head-Neuroscience at Novartis Institutes for Biomedical Research, Inc. He also served as the President & Chief Scientific Officer at uniQure NV from 2020 to 2023.
Additionally, he has experience as a Professor at Stanford University School of Medicine.
Dr. Dolmetsch completed his undergraduate degree at Brown University and obtained his doctorate from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UNIQURE N.V.
0.09% | 2024-03-30 | 42,648 ( 0.09% ) | 211 108 $ | 2024-05-30 |
Ricardo Dolmetsch active positions
| Companies | Position | Start |
|---|---|---|
Trialspark, Inc.
 Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Consultant / Advisor | - |
Former positions of Ricardo Dolmetsch
| Companies | Position | End |
|---|---|---|
| UNIQURE N.V. | President | 2023-10-04 |
The Allen Institute for Brain Science
 The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Director/Board Member | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Ricardo Dolmetsch
| Brown University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Private companies | 3 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
The Allen Institute for Brain Science
The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Commercial Services |
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Finance |
- Stock Market
- Insiders
- Ricardo Dolmetsch
